a recombinant human soluble p55 tumor necrosis factor binding protein for the treatment of a number of disorders, including Crohn's disease, psoriasis and psoriatic arthritis; TNFbp (pharmacologic) is the dimeric polyethylene glycol linked form of the type I soluble receptor of tumor necrosis factor (TNF) that acts as a TNF inhibitor
Also Known As:
Onercept; PEG-(rsTNF-RI)2; PEG-linked dimeric form of rsTNF-RI; PEG-linked dimeric type I soluble receptor of TNF; Receptor(55), TNF; TNF Receptor p55; TNF-sR55; TNFRp55; Tumor Necrosis Factor Receptor 55; glycoprotein TNF-BP (tumor necrosis factor-binding protein) (human disulfide variant 1); r-hTBP-1; recombinant human soluble p55 tumour necrosis factor receptor; tumor necrosis factor receptor type I, P55 soluble fragment